Overview

Pharmaceutical research and development is a journey defined by uncertainty, steep investment, long timelines, and an unwavering commitment to patients. Today, this journey is increasingly shaped by data - more abundant, more complex, and more consequential than ever before. The Dose of Data: Analytics in Pharmaceutical Research & Development aims to demystify this landscape, showing how analytics transforms raw scientific, clinical, and real-world information into evidence that guides discovery, development, and decision-making. From early-stage target selection to post-marketing surveillance, analytics serves as the connective tissue that links hypotheses to outcomes, experiments to insight, and ultimately, molecules to medicines. This book, anchored by the tagline From Molecules to Medicines: Turning R&D Data into Evidence and Decisions is designed as a foundational guide for scientists, analysts, clinicians, and R&D professionals navigating modern drug development. The chapters that follow bring together key principles from discovery, preclinical research, clinical trials, safety science, real-world evidence, and advanced analytics. Without assuming deep technical or statistical expertise, the content offers a structured and intuitive understanding of how data flows across the R&D lifecycle and how thoughtful analysis enhances quality, reduces risk, and accelerates development. Whether you are entering the field or strengthening your expertise, this book provides a practical lens on the analytic thinking that powers innovation in pharmaceutical R&D.

Full Product Details

9798276400679

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available